Fig. 2From: Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancerA high peripheral basophil count at baseline was prognostic for unfavorable survival due to the anti-PD-1 plus chemotherapy combination. Progression-free survival and overall survival for all patients (a, b), patients receiving first-line (c, d), and second-line or later (e, f) anti-PD-1 plus chemotherapy stratified by peripheral basophil counts at baselineBack to article page